| Year |
Citation |
Score |
| 2023 |
Denne T, Winfrey LC, Moore C, Whitner C, D'Silva T, Soumyanath A, Shinto L, Hiller A, Meshul CK. Recovery of motor function is associated with rescue of glutamate biomarkers in the striatum and motor cortex following treatment with Mucuna pruriens in a murine model of Parkinsons disease. Molecular and Cellular Neurosciences. 126: 103883. PMID 37527694 DOI: 10.1016/j.mcn.2023.103883 |
0.321 |
|
| 2020 |
Moore C, Xu M, Bohlen JK, Meshul CK. Differential ultrastructural alterations in the Vglut2 glutamatergic input to the substantia nigra pars compacta/pars reticulata following nigrostriatal dopamine loss in a progressive mouse model of Parkinson's disease. The European Journal of Neuroscience. PMID 32619030 DOI: 10.1111/ejn.14894 |
0.338 |
|
| 2020 |
Bentea E, Villers A, Moore C, Funk AJ, O'Donovan SM, Verbruggen L, Lara O, Janssen P, De Pauw L, Declerck NB, DePasquale EAK, Churchill MJ, Sato H, Hermans E, Arckens L, ... Meshul CK, et al. Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter. Molecular Psychiatry. PMID 32366950 DOI: 10.1038/s41380-020-0751-3 |
0.398 |
|
| 2020 |
Massaquoi MS, Liguore WA, Churchill MJ, Moore C, Melrose HL, Meshul CK. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease. Neuroscience. PMID 32142862 DOI: 10.1016/j.neuroscience.2020.02.046 |
0.439 |
|
| 2019 |
Churchill MJ, Cantu MA, Kasanga EA, Moore C, Salvatore MF, Meshul CK. Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson's disease. Neuroscience. PMID 31220543 DOI: 10.1016/J.Neuroscience.2019.06.006 |
0.391 |
|
| 2019 |
Leal PC, Bispo JMM, Lins LCRF, Souza MF, Gois AM, Moore C, Marchioro M, Ribeiro AM, Silva RH, Meshul CK, Santos JR. Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism. Brain Research Bulletin. PMID 30641120 DOI: 10.1016/J.Brainresbull.2019.01.009 |
0.659 |
|
| 2019 |
Lara O, Bentea E, Villers A, Moore C, Funk A, O'Donovan S, Verbruggen L, De Pauw L, Depasquale E, Churchill M, Sato H, Ris L, Meshul C, McCullumsmith R, Massie A. The cystine/glutamate antiporter system xc- as modulator of corticostriatal neurotransmission Frontiers in Neuroscience. 13. DOI: 10.3389/Conf.Fnins.2019.96.00050 |
0.335 |
|
| 2018 |
Shimamoto A, Rappeneau V, Munjal H, Farris T, Davis C, Wilson A, Edwards M, Moore C, Reynolds C, Meshul CK. Glutamate-glutamine transfer and chronic stress-induced sex differences in cocaine responses. Neuroscience. PMID 30240589 DOI: 10.1016/j.neuroscience.2018.09.009 |
0.393 |
|
| 2018 |
Torres ERS, Akinyeke T, Stagaman K, Duvoisin RM, Meshul CK, Sharpton TJ, Raber J. Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice. Frontiers in Behavioral Neuroscience. 12: 140. PMID 30072879 DOI: 10.3389/Fnbeh.2018.00140 |
0.363 |
|
| 2018 |
Elliott JE, De Luche SE, Churchill MJ, Moore C, Cohen AS, Meshul CK, Lim MM. Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice. Sleep. PMID 29315422 DOI: 10.1093/sleep/zsx212 |
0.333 |
|
| 2018 |
Bentea E, Moore C, Villers A, Churchill MJ, Hood RL, Deneyer L, Verbruggen L, Albertini G, Sato H, Ris L, Meshul CK, Massie A. 12.3 SYSTEM XC- AS A NOVEL MODULATOR OF CORTICOSTRIATAL NEUROTRANSMISSION Schizophrenia Bulletin. 44: S20-S20. DOI: 10.1093/schbul/sby014.046 |
0.39 |
|
| 2017 |
Parievsky A, Moore C, Kamdjou T, Cepeda C, Meshul CK, Levine MS. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 108: 29-44. PMID 28757327 DOI: 10.1016/J.Nbd.2017.07.020 |
0.388 |
|
| 2017 |
Bentea E, Moore C, Deneyer L, Verbruggen L, Churchill MJ, Hood RL, Meshul CK, Massie A. Plastic changes at corticostriatal synapses predict improved motor function in a partial lesion model of Parkinson's disease. Brain Research Bulletin. PMID 28232022 DOI: 10.1016/j.brainresbull.2017.02.005 |
0.439 |
|
| 2017 |
Bentea E, Moore C, Churchill M, Villers A, Hood R, Deneyer L, Verbruggen L, Albertini G, Sato H, Ris L, Meshul C, Massie A. Pre- and postsynaptic changes at cortico-striatal synapses in xCT deficient mice Frontiers in Neuroscience. 11. DOI: 10.3389/conf.fnins.2017.94.00050 |
0.311 |
|
| 2016 |
Hood RL, Liguore WA, Moore C, Pflibsen L, Meshul CK. Exercise intervention increases spontaneous locomotion but fails to attenuate dopaminergic system loss in a progressive MPTP model in aged mice. Brain Research. PMID 27350080 DOI: 10.1016/j.brainres.2016.06.032 |
0.329 |
|
| 2015 |
Tamburrino A, Churchill MJ, Wan OW, Colino-Sanguino Y, Ippolito R, Bergstrand S, Wolf DA, Herz NJ, Sconce MD, Björklund A, Meshul CK, Decressac M. Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease. Acta Neuropathologica Communications. 3: 84. PMID 26666562 DOI: 10.1186/S40478-015-0263-6 |
0.334 |
|
| 2015 |
Pflibsen L, Stang KA, Sconce MD, Wilson VB, Hood RL, Meshul CK, Mitchell SH. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Journal of Neuroscience Research. 93: 1849-64. PMID 26332770 DOI: 10.1002/jnr.23638 |
0.44 |
|
| 2015 |
Jimenez VA, Helms CM, Cornea A, Meshul CK, Grant KA. An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques. Frontiers in Cellular Neuroscience. 9: 260. PMID 26236193 DOI: 10.3389/Fncel.2015.00260 |
0.73 |
|
| 2015 |
Spinelli KJ, Osterberg VR, Meshul CK, Soumyanath A, Unni VK. Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice. Plos One. 10: e0128510. PMID 26035833 DOI: 10.1371/journal.pone.0128510 |
0.308 |
|
| 2015 |
Sconce MD, Churchill MJ, Greene RE, Meshul CK. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease. Neuroscience. 299: 156-74. PMID 25943481 DOI: 10.1016/j.neuroscience.2015.04.069 |
0.401 |
|
| 2015 |
Bentea E, Sconce MD, Churchill MJ, Van Liefferinge J, Sato H, Meshul CK, Massie A. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT. Neuroscience Letters. 593: 1-6. PMID 25766755 DOI: 10.1016/j.neulet.2015.03.013 |
0.445 |
|
| 2015 |
Jimenez VA, Helms CM, Cornea A, Meshul CK, Grant KA. An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques Frontiers in Cellular Neuroscience. 9. DOI: 10.3389/fncel.2015.00260 |
0.71 |
|
| 2014 |
Spinelli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E, Moore C, Meshul CK, Unni VK. Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 2037-50. PMID 24501346 DOI: 10.1523/JNEUROSCI.2581-13.2014 |
0.302 |
|
| 2013 |
Mao P, Meshul CK, Thuillier P, Reddy PH. Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's Disease. Pharmaceuticals (Basel, Switzerland). 6: 108-23. PMID 23543038 DOI: 10.3390/ph6010108 |
0.356 |
|
| 2012 |
Munhall AC, Wu YN, Belknap JK, Meshul CK, Johnson SW. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons. Neurotoxicology. 33: 429-35. PMID 22521663 DOI: 10.1016/j.neuro.2012.04.006 |
0.414 |
|
| 2012 |
Walker RH, Moore C, Davies G, Dirling LB, Koch RJ, Meshul CK. Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. Plos One. 7: e32919. PMID 22427909 DOI: 10.1371/journal.pone.0032919 |
0.463 |
|
| 2012 |
Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Neurobiology of Disease. 45: 1051-67. PMID 22198503 DOI: 10.1016/J.Nbd.2011.12.024 |
0.438 |
|
| 2011 |
Petzinger GM, Fisher BE, Akopian G, Holschneider DP, Wood R, Walsh JP, Lund B, Meshul C, Vuckovic M, Jakowec MW. The role of exercise in facilitating basal ganglia function in Parkinson's disease. Neurodegenerative Disease Management. 1: 157-170. PMID 23805167 DOI: 10.2217/Nmt.11.16 |
0.314 |
|
| 2011 |
Goldberg NR, Hampton T, McCue S, Kale A, Meshul CK. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning. Journal of Neuroscience Research. 89: 1698-706. PMID 21748776 DOI: 10.1002/Jnr.22699 |
0.419 |
|
| 2011 |
Goldberg NR, Meshul CK. Effect of intermittent washout periods on progressive lesioning of the nigrostriatal pathway with 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience. 182: 203-7. PMID 21402128 DOI: 10.1016/J.Neuroscience.2011.03.015 |
0.307 |
|
| 2011 |
Goldberg NR, Haack AK, Lim NS, Janson OK, Meshul CK. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 180: 256-71. PMID 21335067 DOI: 10.1016/J.Neuroscience.2011.02.027 |
0.769 |
|
| 2011 |
Smith BA, Goldberg NR, Meshul CK. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse. Brain Research. 1386: 70-80. PMID 21315689 DOI: 10.1016/J.Brainres.2011.02.003 |
0.407 |
|
| 2011 |
Goldberg NR, Haack AK, Meshul CK. Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease. Neuroscience. 172: 443-52. PMID 20933577 DOI: 10.1016/J.Neuroscience.2010.09.062 |
0.76 |
|
| 2010 |
Massie A, Goursaud S, Schallier A, Vermoesen K, Meshul CK, Hermans E, Michotte Y. Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats. Neurochemistry International. 57: 572-8. PMID 20643175 DOI: 10.1016/j.neuint.2010.07.004 |
0.456 |
|
| 2010 |
Walker RH, Davies G, Koch RJ, Haack AK, Moore C, Meshul CK. Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6-hydroxydopamine-lesioned rats. Journal of Neuroscience Research. 88: 2964-75. PMID 20544826 DOI: 10.1002/jnr.22446 |
0.768 |
|
| 2010 |
McKee BL, Keyghobadi M, Tozier De La Poterie AP, Meshul CK. Lesion of the ventromedial nucleus of the thalamus blocks acute cocaine-induced changes in striatal glutamate. Synapse (New York, N.Y.). 64: 445-8. PMID 20169577 DOI: 10.1002/syn.20749 |
0.781 |
|
| 2010 |
Paquette MA, Anderson AM, Lewis JR, Meshul CK, Johnson SW, Paul Berger S. MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. Neuropharmacology. 58: 1002-8. PMID 20079362 DOI: 10.1016/j.neuropharm.2010.01.003 |
0.349 |
|
| 2009 |
Meredith GE, Totterdell S, Beales M, Meshul CK. Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Experimental Neurology. 219: 334-40. PMID 19523952 DOI: 10.1016/j.expneurol.2009.06.005 |
0.398 |
|
| 2009 |
Walker RH, Koch RJ, Sweeney JE, Moore C, Meshul CK. Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum. Neuroreport. 20: 770-5. PMID 19373115 DOI: 10.1097/WNR.0b013e32832ad556 |
0.462 |
|
| 2009 |
Paquette MA, Foley K, Brudney EG, Meshul CK, Johnson SW, Berger SP. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism. Psychopharmacology. 204: 743-54. PMID 19283364 DOI: 10.1007/s00213-009-1522-7 |
0.309 |
|
| 2009 |
Meyer PJ, Meshul CK, Phillips TJ. Ethanol- and cocaine-induced locomotion are genetically related to increases in accumbal dopamine. Genes, Brain, and Behavior. 8: 346-55. PMID 19220481 DOI: 10.1111/J.1601-183X.2009.00481.X |
0.728 |
|
| 2009 |
Walker RH, Koch RJ, Moore C, Meshul CK. Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism. Synapse (New York, N.Y.). 63: 136-46. PMID 19021215 DOI: 10.1002/syn.20592 |
0.437 |
|
| 2009 |
Walker R, Sweeney J, Koch R, Moore C, Meshul C. P2.059 Effects of subthalamic nucleus lesions and short-term stimulation upon striatal glutamate levels in awake intact and 6-hydroxy/dopamine-lesioned rats Parkinsonism & Related Disorders. 15: S104. DOI: 10.1016/S1353-8020(09)70410-9 |
0.431 |
|
| 2009 |
Sashkin N, Sweeney J, Dirling L, Moore C, Koch R, Walker R, Meshul C. P2.013 Enriched environment partially reverses dopamine cell loss following MPTP in mice Parkinsonism & Related Disorders. 15: S91. DOI: 10.1016/S1353-8020(09)70364-5 |
0.349 |
|
| 2008 |
Paquette MA, Brudney EG, Putterman DB, Meshul CK, Johnson SW, Berger SP. Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias. Neuroreport. 19: 111-5. PMID 18281903 DOI: 10.1097/WNR.0b013e3282f3b0d1 |
0.327 |
|
| 2007 |
Gunzler SA, Shakil S, Carlson NE, Nutt JG, Meshul CK. Low doses of apomorphine transiently reduce locomotor activity in MPTP-treated mice. Neuroscience Letters. 428: 64-7. PMID 17964074 DOI: 10.1016/j.neulet.2007.09.049 |
0.355 |
|
| 2007 |
Chen YT, Collins LL, Uno H, Chou SM, Meshul CK, Chang SS, Chang C. Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor. Brain Research. 1168: 72-82. PMID 17706948 DOI: 10.1016/J.Brainres.2007.06.069 |
0.337 |
|
| 2007 |
Back SA, Craig A, Kayton RJ, Luo NL, Meshul CK, Allcock N, Fern R. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 334-47. PMID 16757980 DOI: 10.1038/Sj.Jcbfm.9600344 |
0.346 |
|
| 2005 |
Holmer HK, Keyghobadi M, Moore C, Meshul CK. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 136: 333-41. PMID 16198485 DOI: 10.1016/j.neuroscience.2005.08.003 |
0.348 |
|
| 2005 |
Shakil SS, Holmer HK, Moore C, Abernathy AT, Jakowec MW, Petzinger GM, Meshul CK. High and low responders to novelty show differential effects in striatal glutamate. Synapse (New York, N.Y.). 58: 200-7. PMID 16138315 DOI: 10.1002/Syn.20198 |
0.455 |
|
| 2005 |
Sirvanci S, Meshul CK, Onat F, San T. Glutamate and GABA immunocytochemical electron microscopy in the hippocampal dentate gyrus of normal and genetic absence epilepsy rats. Brain Research. 1053: 108-15. PMID 16038886 DOI: 10.1016/j.brainres.2005.06.024 |
0.318 |
|
| 2005 |
Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Synapse (New York, N.Y.). 57: 100-12. PMID 15906381 DOI: 10.1002/syn.20163 |
0.454 |
|
| 2005 |
McKee BL, Meshul CK. Time-dependent changes in extracellular glutamate in the rat dorsolateral striatum following a single cocaine injection. Neuroscience. 133: 605-13. PMID 15878803 DOI: 10.1016/j.neuroscience.2005.02.020 |
0.775 |
|
| 2005 |
Touchon JC, Holmer HK, Moore C, McKee BL, Frederickson J, Meshul CK. Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine. Experimental Neurology. 193: 131-40. PMID 15817272 DOI: 10.1016/J.Expneurol.2004.11.023 |
0.784 |
|
| 2004 |
Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK. Dopamine modulates release from corticostriatal terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9541-52. PMID 15509741 DOI: 10.1523/Jneurosci.2891-04.2004 |
0.443 |
|
| 2004 |
Dervan AG, Meshul CK, Beales M, McBean GJ, Moore C, Totterdell S, Snyder AK, Meredith GE. Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease. Experimental Neurology. 190: 145-56. PMID 15473988 DOI: 10.1016/j.expneurol.2004.07.004 |
0.43 |
|
| 2004 |
Fisher BE, Petzinger GM, Nixon K, Hogg E, Bremmer S, Meshul CK, Jakowec MW. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. Journal of Neuroscience Research. 77: 378-90. PMID 15248294 DOI: 10.1002/Jnr.20162 |
0.353 |
|
| 2004 |
Touchon JC, Moore C, Frederickson J, Meshul CK. Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations. Synapse (New York, N.Y.). 51: 287-98. PMID 14696016 DOI: 10.1002/Syn.10306 |
0.473 |
|
| 2004 |
Kozell LB, Meshul CK. Nerve terminal glutamate immunoreactivity in the rat nucleus accumbens and ventral tegmental area after a short withdrawal from cocaine. Synapse (New York, N.Y.). 51: 224-32. PMID 14696010 DOI: 10.1002/syn.10304 |
0.423 |
|
| 2003 |
McNeill TH, Brown SA, Hogg E, Cheng HW, Meshul CK. Synapse replacement in the striatum of the adult rat following unilateral cortex ablation. The Journal of Comparative Neurology. 467: 32-43. PMID 14574678 DOI: 10.1002/Cne.10907 |
0.335 |
|
| 2003 |
Sirvanci S, Meshul CK, Onat F, San T. Immunocytochemical analysis of glutamate and GABA in hippocampus of genetic absence epilepsy rats (GAERS). Brain Research. 988: 180-8. PMID 14519540 DOI: 10.1016/S0006-8993(03)03349-3 |
0.331 |
|
| 2003 |
Robinson S, Freeman P, Moore C, Touchon JC, Krentz L, Meshul CK. Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. Experimental Neurology. 180: 74-87. PMID 12668150 DOI: 10.1016/S0014-4886(02)00050-X |
0.467 |
|
| 2003 |
Kozell LB, Meshul CK. Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine Psychopharmacology. 165: 337-345. PMID 12459930 DOI: 10.1007/S00213-002-1296-7 |
0.423 |
|
| 2003 |
Jakowec MW, Fisher B, Nixon K, Hogg E, Meshul C, Bremmer S, McNeill T, Petzinger GM. Neuroplasticity in the MPTP-lesioned mouse and nonhuman primate Annals of the New York Academy of Sciences. 991: 298-301. DOI: 10.1111/J.1749-6632.2003.Tb07489.X |
0.331 |
|
| 2002 |
See RE, Berglind WJ, Krentz L, Meshul CK. Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of gamma-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats. Journal of Neurochemistry. 82: 172-80. PMID 12091478 DOI: 10.1046/J.1471-4159.2002.00974.X |
0.348 |
|
| 2002 |
Meshul CK, Kamel D, Moore C, Kay TS, Krentz L. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. Experimental Neurology. 175: 257-74. PMID 12009777 DOI: 10.1006/exnr.2002.7900 |
0.434 |
|
| 2001 |
Robinson S, Krentz L, Moore C, Meshul CK. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats. Synapse (New York, N.Y.). 42: 54-61. PMID 11668591 DOI: 10.1002/Syn.1099 |
0.456 |
|
| 2001 |
Kozell LB, Meshul CK. The effects of acute or repeated cocaine administration on nerve terminal glutamate within the rat mesolimbic system. Neuroscience. 106: 15-25. PMID 11564413 DOI: 10.1016/S0306-4522(01)00274-3 |
0.425 |
|
| 2001 |
Andreassen OA, Meshul CK, Moore C, Jørgensen HA. Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration. Psychopharmacology. 157: 11-9. PMID 11512038 DOI: 10.1007/s002130100767 |
0.416 |
|
| 2000 |
Meshul CK, Cogen JP, Cheng HW, Moore C, Krentz L, McNeill TH. Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway. Experimental Neurology. 165: 191-206. PMID 10964498 DOI: 10.1006/Exnr.2000.7467 |
0.449 |
|
| 2000 |
Meshul CK, Allen C. Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion. Synapse (New York, N.Y.). 36: 129-42. PMID 10767060 DOI: 10.1002/(SICI)1098-2396(200005)36:2<129::AID-SYN6>3.0.CO;2-4 |
0.498 |
|
| 1999 |
Buckman JF, Meshul CK. Glial differences between naïve withdrawal seizure-prone and -resistant mice. Alcoholism, Clinical and Experimental Research. 23: 1905-13. PMID 10630609 DOI: 10.1111/J.1530-0277.1999.Tb04090.X |
0.365 |
|
| 1999 |
Buckman JF, Meshul CK, Finn DA, Janowsky A. Glutamate uptake in mice bred for ethanol withdrawal severity. Psychopharmacology. 143: 174-82. PMID 10326780 DOI: 10.1007/S002130050933 |
0.349 |
|
| 1999 |
Burrows KB, Meshul CK. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. Neuroscience. 90: 833-50. PMID 10218784 DOI: 10.1016/S0306-4522(98)00506-5 |
0.376 |
|
| 1999 |
Meshul CK, Emre N, Nakamura CM, Allen C, Donohue MK, Buckman JF. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience. 88: 1-16. PMID 10051185 DOI: 10.1016/S0306-4522(98)00189-4 |
0.449 |
|
| 1998 |
Keys AS, Mark GP, Emre N, Meshul CK. Reduced glutamate immunolabeling in the nucleus accumbens following extended withdrawal from self-administered cocaine. Synapse (New York, N.Y.). 30: 393-401. PMID 9826231 DOI: 10.1002/(Sici)1098-2396(199812)30:4<393::Aid-Syn6>3.0.Co;2-H |
0.433 |
|
| 1998 |
Meshul CK, Noguchi K, Emre N, Ellison G. Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens. Synapse (New York, N.Y.). 30: 211-20. PMID 9723791 DOI: 10.1002/(Sici)1098-2396(199810)30:2<211::Aid-Syn11>3.0.Co;2-4 |
0.42 |
|
| 1997 |
Burrows KB, Meshul CK. Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex. Synapse (New York, N.Y.). 27: 133-44. PMID 9266774 DOI: 10.1002/(SICI)1098-2396(199710)27:2<133::AID-SYN4>3.0.CO;2-F |
0.483 |
|
| 1997 |
Buckman JF, Meshul CK. Immunocytochemical analysis of glutamate and GABA in selectively bred mice. Brain Research. 760: 193-203. PMID 9237535 DOI: 10.1016/S0006-8993(97)00281-3 |
0.357 |
|
| 1996 |
Meshul CK, Buckman JF, Allen C, Riggan JP, Feller DJ. Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment. Synapse (New York, N.Y.). 22: 350-61. PMID 8867029 DOI: 10.1002/(Sici)1098-2396(199604)22:4<350::Aid-Syn6>3.0.Co;2-A |
0.432 |
|
| 1996 |
Meshul CK, Bunker GL, Mason JN, Allen C, Janowsky A. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. Journal of Neurochemistry. 67: 1965-73. PMID 8863502 DOI: 10.1046/J.1471-4159.1996.67051965.X |
0.392 |
|
| 1996 |
Meshul CK, Andreassen OA, Allen C, Jørgensen HA. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol. Psychopharmacology. 125: 238-47. PMID 8815959 DOI: 10.1007/BF02247334 |
0.337 |
|
| 1995 |
Meshul CK, Stallbaumer RK, Allen C. GM1 ganglioside administration partially counteracts the morphological changes associated with haloperidol treatment within the dorsal striatum of the rat. Psychopharmacology. 121: 461-9. PMID 8619009 DOI: 10.1007/BF02246494 |
0.43 |
|
| 1994 |
Meshul CK, Stallbaumer RK, Taylor B, Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Research. 648: 181-95. PMID 7922533 DOI: 10.1016/0006-8993(94)91117-7 |
0.429 |
|
| 1994 |
Meshul CK, Tan SE. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse (New York, N.Y.). 18: 205-17. PMID 7855733 DOI: 10.1002/syn.890180306 |
0.374 |
|
| 1992 |
Meshul CK, Janowsky A, Casey DE, Stallbaumer RK, Taylor B. Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology. 106: 45-52. PMID 1531388 DOI: 10.1007/Bf02253587 |
0.412 |
|
| 1992 |
See RE, Chapman MA, Meshul CK. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse (New York, N.Y.). 12: 147-54. PMID 1362290 DOI: 10.1002/syn.890120208 |
0.318 |
|
| 1990 |
Meshul CK, Hopkins WF. Presynaptic ultrastructural correlates of long-term potentiation in the CA1 subfield of the hippocampus. Brain Research. 514: 310-9. PMID 2357543 DOI: 10.1016/0006-8993(90)91426-H |
0.303 |
|
| 1990 |
Meshul CK, Kriho V, Kriho N, Hopkins WF, Matsumura F, Pappas GD. Calcium channel blocker influences the density of alpha-actinin labeling at the rat neuromuscular junction. Muscle & Nerve. 13: 348-54. PMID 2355947 DOI: 10.1002/mus.880130411 |
0.508 |
|
| 1989 |
Meshul CK, Casey DE. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Research. 489: 338-46. PMID 2568156 DOI: 10.1016/0006-8993(89)90867-6 |
0.434 |
|
| 1985 |
Meshul CK, Boyne AF, Deshpande SS, Albuquerque EX. Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles. Experimental Neurology. 89: 96-114. PMID 4007120 DOI: 10.1016/0014-4886(85)90268-7 |
0.414 |
|
| 1984 |
Meshul CK, Pappas GD. The relationship of pinocytosis and synaptic vesicles at the frog neuromuscular junction. Brain Research. 290: 1-18. PMID 6607088 DOI: 10.1016/0006-8993(84)90730-3 |
0.461 |
|
| Show low-probability matches. |
